All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

D. Hughes; D.A. Hughes; [No Value] All Wales Strategy Group.

All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

D. Hughes
, D.A. Hughes
, [No Value] All Wales Strategy Group.

NHS Wales

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Iaith wreiddiol	Saesneg
Cyhoeddwr	Unknown
Corff comisiynu	NHS Wales
Argraffiad	2009
Statws	Cyhoeddwyd - 1 Ion 2009

Ffeiliau eraill a chysylltiadau

http://www.wales.nhs.uk/sites3/Documents/371/Tacrolimus%20_advagraf_%20FAR.pdf

Dyfynnu hyn

Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2009). All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. (2009 gol.) Unknown.

Hughes, D. ; Hughes, D.A. ; All Wales Strategy Group., [No Value]. / All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 gol. Unknown, 2009.

@book{f2032ba644e047d1a08adcdf5bac8425,

title = "All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.",

author = "D. Hughes and D.A. Hughes and \{All Wales Strategy Group.\}, \{[No Value]\}",

year = "2009",

month = jan,

day = "1",

language = "English",

publisher = "Unknown",

edition = "2009",

}

Hughes, D, Hughes, DA & All Wales Strategy Group., NV 2009, All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 gol., Unknown.

All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2009 gol. Unknown, 2009.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/Tacrolimus%20_advagraf_%20FAR.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

PB - Unknown

ER -

Hughes D, Hughes DA, All Wales Strategy Group. NV. All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 gol. Unknown, 2009.